Pacira Biosciences Inc (OQ:PCRX)

Business Focus: Pharmaceuticals

Competitors with Recent Insider Filings
Merck & Co. (N:MRK)
Pfizer (N:PFE)
Odonate Therapeutics (OQ:ODT)
Latest 10 SEC filings (by transaction date) for PCRX within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET August 24th, 2019
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Aug 16/19 Aug 15/19 Stack David M Direct Ownership Stock Option (Right to Buy) M - Exercise or conversion exempt under rule 16b-3 -12,849  
Aug 16/19 Aug 15/19 Stack David M Direct Ownership Common Stock S - Open market or private sale -2,391 $39.61
Aug 16/19 Aug 15/19 Stack David M Direct Ownership Common Stock S - Open market or private sale -10,458 $39.05
Aug 16/19 Aug 15/19 Stack David M Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 12,849 $10.81
Aug 16/19 Aug 14/19 Williams Kristen Marie Direct Ownership Common Stock S - Open market or private sale -6,252 $39.49
Jul 10/19 Jul 8/19 Stack David M Direct Ownership Common Stock S - Open market or private sale -700 $43.42
Jul 10/19 Jul 8/19 Stack David M Direct Ownership Common Stock S - Open market or private sale -12,415 $42.85
Jul 3/19 Jul 2/19 Reinhardt Max Direct Ownership Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 200,000  
Jun 13/19 Jun 11/19 Stack David M Direct Ownership Stock Option (Right to Buy) M - Exercise or conversion exempt under rule 16b-3 -9,000  
Jun 13/19 Jun 11/19 Stack David M Direct Ownership Stock Option (Right to Buy) M - Exercise or conversion exempt under rule 16b-3 -15,000  
Sign up or login above to see all SEC filings within the past 6 months.
Latest 10 SEC filings (by filing date) for PCRX within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET August 24th, 2019
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Aug 16/19 Aug 15/19 Stack David M Direct Ownership Stock Option (Right to Buy) M - Exercise or conversion exempt under rule 16b-3 -12,849  
Aug 16/19 Aug 15/19 Stack David M Direct Ownership Common Stock S - Open market or private sale -2,391 $39.61
Aug 16/19 Aug 15/19 Stack David M Direct Ownership Common Stock S - Open market or private sale -10,458 $39.05
Aug 16/19 Aug 15/19 Stack David M Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 12,849 $10.81
Aug 16/19 Aug 14/19 Williams Kristen Marie Direct Ownership Common Stock S - Open market or private sale -6,252 $39.49
Jul 10/19 Jul 8/19 Stack David M Direct Ownership Common Stock S - Open market or private sale -700 $43.42
Jul 10/19 Jul 8/19 Stack David M Direct Ownership Common Stock S - Open market or private sale -12,415 $42.85
Jul 3/19 Jul 2/19 Reinhardt Max Direct Ownership Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 200,000  
Jun 13/19 Jun 11/19 Stack David M Direct Ownership Stock Option (Right to Buy) M - Exercise or conversion exempt under rule 16b-3 -9,000  
Jun 13/19 Jun 11/19 Stack David M Direct Ownership Stock Option (Right to Buy) M - Exercise or conversion exempt under rule 16b-3 -15,000  
Sign up or login above to see all SEC filings within the past 6 months.
Sign up or login above to see the past 6 months of filings sorted by insider. .
Get holdings trends & enhanced insider charts in PDF now
Comment On!
140

Twitter

Search (past week) for $PCRX

StockTwits